Evidence map›Paper›PMID 28786929›Full record

ArticleNutrients2017

Gluten-Free Diet Indications, Safety, Quality, Labels, and Challenges.

Kamran Rostami, Justine Bold, Alison Parr, Matt W Johnson

Open access · goldAbstract readEditorial
In one paragraph

Article in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. The global burden of coeliac disease: opportunities and challenges.Nature reviews. Gastroenterology & hepatology · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. An algorithm for differentiating food antigen-related gastrointestinal symptoms.Gastroenterology and hepatology from bed to bench · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kamran RostamiDepartment of Gastroenterology, Milton Keynes University Hospital, Milton Keynes MK6 5LD, UK. kamran.rostami@nhs.net.
Justine BoldAllied Health and Social Sciences, Institute of Health and Society University of Worcester, Worcester WR2 6AJ, UK. j.bold@worc.ac.uk.
Alison ParrFreelance Nutrition Therapist, Manchester M33 5PD, UK. alison_parr@hotmail.com.
Matt W JohnsonDepartment of Gastroenterology, Luton and Dunstable University Hospital, Luton LU4 0DZ, UK. matthew.johnson@ldh.nhs.uk.
Luton and Dunstable Hospital · GBMilton Keynes Hospital · GBUniversity of Worcester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A gluten-free diet (GFD) is the safest treatment modality in patient with coeliac disease (CD) and other gluten-related disorders. Contamination and diet compliance are important factors behind persistent symptoms in patients with gluten related-disorders, in particular CD. How much gluten can be tolerated, how safe are the current gluten-free (GF) products, what are the benefits and side effects of GFD? Recent studies published in

Indexed as

Foods, SpecializedLegislation, FoodCeliac DiseaseDiet, Gluten-FreeFood ContaminationFood IndustryGlutensHumansGlutenscoeliac diseasegluten-free dietnon-coeliac gluten sensitivity

Identifiers

PMID28786929
PMCPMC5579639
OpenAlexW2745146559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.